Olaparib combined with low-dose chemotherapy for relapsed <i>AML1::ETO</i> positive acute myeloid leukemia in elderly patient.

Lin, Li; Xue, Song; Chen, Jiaqi; Gu, Cuihong; Zhang, Jingzheng; Xing, Enhong; Wang, Wei; Wang, Lihong; Zhang, Zhihua

Olaparib combined with low-dose chemotherapy for relapsed AML1::ETO positive acute myeloid leukemia in elderly patient.

Lin, Li; Xue, Song; Chen, Jiaqi; Gu, Cuihong; Zhang, Jingzheng; Xing, Enhong; Wang, Wei; Wang, Lihong; Zhang, Zhihua.

Affiliation

Lin L; Department of Hematology, The Affiliated Hospital of Chengde Medical College, Chengde, People's Republic of China.
Xue S; Department of Bone Marrow Transplant, Beijing Lu Daopei Hospital, Beijing, People's Republic of China.
Chen J; Division of Pathology & Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang, People's Republic of China.
Gu C; Department of Hematology, The Affiliated Hospital of Chengde Medical College, Chengde, People's Republic of China.
Zhang J; Department of Hematology, The Affiliated Hospital of Chengde Medical College, Chengde, People's Republic of China.
Xing E; Department of Central Laboratory, The Affiliated Hospital of Chengde Medical College, Chengde, People's Republic of China.
Wang W; Department of Hematology, The Affiliated Hospital of Chengde Medical College, Chengde, People's Republic of China.
Wang L; Department of Hematology, The Affiliated Hospital of Chengde Medical College, Chengde, People's Republic of China.
Zhang Z; Department of Hematology, The Affiliated Hospital of Chengde Medical College, Chengde, People's Republic of China.

Leuk Lymphoma ; 65(8): 1181-1185, 2024 Aug.

Article in En | MEDLINE | ID: mdl-39041737

Subject(s)

Antineoplastic Combined Chemotherapy Protocols; Leukemia, Myeloid, Acute; Phthalazines; Piperazines; RUNX1 Translocation Partner 1 Protein; Humans; Leukemia, Myeloid, Acute/drug therapy; Leukemia, Myeloid, Acute/genetics; Leukemia, Myeloid, Acute/diagnosis; Leukemia, Myeloid, Acute/pathology; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Piperazines/administration & dosage; Piperazines/therapeutic use; Phthalazines/administration & dosage; Phthalazines/therapeutic use; RUNX1 Translocation Partner 1 Protein/genetics; Aged; Core Binding Factor Alpha 2 Subunit/genetics; Oncogene Proteins, Fusion/genetics; Treatment Outcome; Male; Female; Recurrence; Neoplasm Recurrence, Local/drug therapy; Neoplasm Recurrence, Local/pathology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phthalazines / Piperazines / Leukemia, Myeloid, Acute / Antineoplastic Combined Chemotherapy Protocols / RUNX1 Translocation Partner 1 Protein Limits: Aged / Female / Humans / Male Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2024 Document type: Article Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google